Market Cap 24.48M
Revenue (ttm) 0.00
Net Income (ttm) -2.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 440,900
Avg Vol 5,862,952
Day's Range N/A - N/A
Shares Out 20.74M
Stochastic %K 63%
Beta N/A
Analysts Strong Sell
Price Target $8.33

Company Profile

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The company develops KROS 101, an orally available glucocorticoid-induced tumor necrosis factor receptor (GITR) ligand small-molecule antagonist to deplete regulatory T cells (Tregs) and activate effector T cells to augment the antitumor immune respons...

Industry: Biotechnology
Sector: Healthcare
Phone: 310-948-2356
Address:
2355 Westwood Boulevard, Suite 139, Los Angeles, United States
hbseth
hbseth Aug. 27 at 12:04 AM
$KAPA some people coming to flood this thread with nonsense so they feel smart. Just remember how far we've come. It's about to get real in here. LFG!!!!!!
1 · Reply
Oldshoe
Oldshoe Aug. 26 at 11:05 PM
$KAPA Just to be clear. The remaining ~1.1 million warrants, along with the 884,938 shares held by Armistice, total to be just under 2 million potential dilution shares. That is far less than the 6.425 million warrant shares several people here have mentioned for the "January" warrants. Only 2 million warrants vs current 21 million outstanding shares is low, will be eaten up on volume of interim p2 news. Quite bullish here.
0 · Reply
Oldshoe
Oldshoe Aug. 26 at 9:47 PM
$KAPA FWIW. The 6/30 10-Q indicates the 2 million pfw's Armistice had were exercised prior to the 7/15 safety results ($0.001 exercise price). The actual 3.75 million warrants ($1.40 e.p.) would've been exercised on 7/15, when the conversion price was reached and the ticker had volume. Filings indicate the "January" warrants" were issued between 1/12-1/14, exercisable 6 months from date of issuance. That puts it squarely at 7/15, the day the safety results were released. Frequently see concident timing like this on news releases. Bullish
0 · Reply
Oldshoe
Oldshoe Aug. 26 at 9:20 PM
$KAPA KAPA 6/30 10-Q filed on 8/12, shows 4,088,888 outstanding warrants, 17,743,765 outstanding shares as of 6/30, 20,743,765 outstanding shares as of 8/11. So 20,743,765 - 17,743,765 = 3 million new shares added between 6/30 and 8/11 (most of which almost certainly from warrant conversion around 7/15). The 6/30 10-Q shows 4,088,888 outstanding warrants (p.14), subtracting the 3 million new shares that resulted from warrant conversion would be 4,088,888 - 3 million = ~1.1 million remaining warrants outstanding as of 8/11 (in my opinion this is the number of outstanding warrants as of 8/11, within reasonable accuracy). The "January" pre-funded warrants issued to Armistice have all been exercised as of 6/30 (6/30 10-Q p.12). Should mention, Armistice owns 884,938 shares (8/14 13G filing). https://www.sec.gov/search-filings
1 · Reply
StrawberryRips
StrawberryRips Aug. 26 at 7:56 PM
$KAPA dip getting bought 👀 not a lot of ppl on this yet 😴
1 · Reply
TekuTrader
TekuTrader Aug. 26 at 7:40 PM
0 · Reply
simplifocused
simplifocused Aug. 26 at 6:59 PM
$KAPA https://www.marketbeat.com/stocks/NYSEAMERICAN/KAPA/forecast/ NFA
1 · Reply
Landomos
Landomos Aug. 26 at 6:56 PM
$KAPA Catalyst in September per below, https://www.newsfilecorp.com/release/260333/CEO.CAs-Inside-the-Boardroom-Kairos-Pharma-CEO-on-Phase-2-Safety-Data-165-Stock-Move-September-Efficacy-Timeline?utm_source=snapi
0 · Reply
simplifocused
simplifocused Aug. 26 at 6:53 PM
$KAPA Vhttps://www.marketbeat.com/stocks/NYSEAMERICAN/KAPA/forecast/ Well doing life saving biomedical companies are being nailed by shorts, even $IVVD $IXHL among many others NFA
0 · Reply
Xtracked
Xtracked Aug. 26 at 6:40 PM
$KAPA Ya... sure. No volume...you have to pay for waiting this long to get in
0 · Reply
Latest News on KAPA
Why Is Kairos Pharma Stock Surging On Tuesday?

Jul 15, 2025, 2:08 PM EDT - 6 weeks ago

Why Is Kairos Pharma Stock Surging On Tuesday?


Kairos Pharma, Ltd. Announces Participation in the D.

May 6, 2025, 8:00 AM EDT - 4 months ago

Kairos Pharma, Ltd. Announces Participation in the D.


Kairos Pharma Ltd. Provides Letter to Stockholders

Apr 24, 2025, 8:00 AM EDT - 4 months ago

Kairos Pharma Ltd. Provides Letter to Stockholders


Kairos Pharma Provides Business Update and Outlook into 2025

Jan 21, 2025, 8:30 AM EST - 7 months ago

Kairos Pharma Provides Business Update and Outlook into 2025


IBN Initiates Coverage of Kairos Pharma Ltd.

Nov 26, 2024, 8:30 AM EST - 9 months ago

IBN Initiates Coverage of Kairos Pharma Ltd.


Kairos Pharma to Present at the LD Micro Main Event XVII

Oct 22, 2024, 9:00 AM EDT - 11 months ago

Kairos Pharma to Present at the LD Micro Main Event XVII


Kairos Pharma Closing of $6.2 Million Initial Public Offering

Sep 17, 2024, 4:29 PM EDT - 1 year ago

Kairos Pharma Closing of $6.2 Million Initial Public Offering


Kairos Pharma Prices $6.2 Million Initial Public Offering

Sep 16, 2024, 10:49 AM EDT - 1 year ago

Kairos Pharma Prices $6.2 Million Initial Public Offering


Kairos Pharma to sell 1.55 million shares in IPO at $4 each

Feb 14, 2024, 6:16 PM EST - 1 year ago

Kairos Pharma to sell 1.55 million shares in IPO at $4 each


Kairos Pharma Files For U.S. IPO

Oct 3, 2023, 3:33 PM EDT - 2 years ago

Kairos Pharma Files For U.S. IPO


hbseth
hbseth Aug. 27 at 12:04 AM
$KAPA some people coming to flood this thread with nonsense so they feel smart. Just remember how far we've come. It's about to get real in here. LFG!!!!!!
1 · Reply
Oldshoe
Oldshoe Aug. 26 at 11:05 PM
$KAPA Just to be clear. The remaining ~1.1 million warrants, along with the 884,938 shares held by Armistice, total to be just under 2 million potential dilution shares. That is far less than the 6.425 million warrant shares several people here have mentioned for the "January" warrants. Only 2 million warrants vs current 21 million outstanding shares is low, will be eaten up on volume of interim p2 news. Quite bullish here.
0 · Reply
Oldshoe
Oldshoe Aug. 26 at 9:47 PM
$KAPA FWIW. The 6/30 10-Q indicates the 2 million pfw's Armistice had were exercised prior to the 7/15 safety results ($0.001 exercise price). The actual 3.75 million warrants ($1.40 e.p.) would've been exercised on 7/15, when the conversion price was reached and the ticker had volume. Filings indicate the "January" warrants" were issued between 1/12-1/14, exercisable 6 months from date of issuance. That puts it squarely at 7/15, the day the safety results were released. Frequently see concident timing like this on news releases. Bullish
0 · Reply
Oldshoe
Oldshoe Aug. 26 at 9:20 PM
$KAPA KAPA 6/30 10-Q filed on 8/12, shows 4,088,888 outstanding warrants, 17,743,765 outstanding shares as of 6/30, 20,743,765 outstanding shares as of 8/11. So 20,743,765 - 17,743,765 = 3 million new shares added between 6/30 and 8/11 (most of which almost certainly from warrant conversion around 7/15). The 6/30 10-Q shows 4,088,888 outstanding warrants (p.14), subtracting the 3 million new shares that resulted from warrant conversion would be 4,088,888 - 3 million = ~1.1 million remaining warrants outstanding as of 8/11 (in my opinion this is the number of outstanding warrants as of 8/11, within reasonable accuracy). The "January" pre-funded warrants issued to Armistice have all been exercised as of 6/30 (6/30 10-Q p.12). Should mention, Armistice owns 884,938 shares (8/14 13G filing). https://www.sec.gov/search-filings
1 · Reply
StrawberryRips
StrawberryRips Aug. 26 at 7:56 PM
$KAPA dip getting bought 👀 not a lot of ppl on this yet 😴
1 · Reply
TekuTrader
TekuTrader Aug. 26 at 7:40 PM
0 · Reply
simplifocused
simplifocused Aug. 26 at 6:59 PM
$KAPA https://www.marketbeat.com/stocks/NYSEAMERICAN/KAPA/forecast/ NFA
1 · Reply
Landomos
Landomos Aug. 26 at 6:56 PM
$KAPA Catalyst in September per below, https://www.newsfilecorp.com/release/260333/CEO.CAs-Inside-the-Boardroom-Kairos-Pharma-CEO-on-Phase-2-Safety-Data-165-Stock-Move-September-Efficacy-Timeline?utm_source=snapi
0 · Reply
simplifocused
simplifocused Aug. 26 at 6:53 PM
$KAPA Vhttps://www.marketbeat.com/stocks/NYSEAMERICAN/KAPA/forecast/ Well doing life saving biomedical companies are being nailed by shorts, even $IVVD $IXHL among many others NFA
0 · Reply
Xtracked
Xtracked Aug. 26 at 6:40 PM
$KAPA Ya... sure. No volume...you have to pay for waiting this long to get in
0 · Reply
StrawberryRips
StrawberryRips Aug. 26 at 6:27 PM
1 · Reply
StrawberryRips
StrawberryRips Aug. 26 at 4:27 PM
$KAPA good consolidation on the daily, upwards pressure
0 · Reply
Xvool
Xvool Aug. 26 at 4:05 PM
$KAPA looks like it wants ti selloff 💩
2 · Reply
KingJames_
KingJames_ Aug. 26 at 2:01 PM
$KAPA Fuck, I missed the dip, but I am watching to catch some cheapies.....
1 · Reply
Limer_814
Limer_814 Aug. 26 at 1:55 PM
$KAPA added 1.18/9
0 · Reply
KingJames_
KingJames_ Aug. 26 at 11:29 AM
$KAPA You dont want to miss this one, ENV105 drug resistance capabilities is meeting unmet medical need, and the phase 2 data rollout is what we've all been waiting for!! Game changer drug!!
1 · Reply
Steelcurtain04
Steelcurtain04 Aug. 26 at 11:17 AM
$KAPA too late to get in good entry ?
0 · Reply
StrawberryRips
StrawberryRips Aug. 26 at 7:50 AM
$KAPA last week before September…
0 · Reply
Oldshoe
Oldshoe Aug. 26 at 1:55 AM
$KAPA Expecting ~$1.12 is the absolute floor before interim p2 news, but not expecting it to go that low. That is the 61.8 fib level of the $1.82 daily chart high from 7/15. It held at that area strong late last week. Will live through any dips. Expecting some price rise continuation this week. Minor expectation of seeing a private placement around 9/8-10 (Wainwright conference) or interim p2 news (expecting that mid Sept. Just a rough estimate on timeline expections imo. Bullish
1 · Reply
Wintermelonjuice
Wintermelonjuice Aug. 25 at 11:45 PM
0 · Reply
Wintermelonjuice
Wintermelonjuice Aug. 25 at 11:42 PM
$KAPA >$10 if interim efficacy data is positive and promising
0 · Reply
Bookshelf1974
Bookshelf1974 Aug. 25 at 8:22 PM
$KAPA good volume today
0 · Reply